
The amendment to Bangladesh's Tobacco Control Act, proposed by the Ministry of Health and Family Welfare to protect public health, has been submitted to the cabinet for approval, according to an October 31 report by bdnews24.
However, tobacco companies, including BAT Bangladesh (BATB) and Japan Tobacco International (JTI), have raised objections. These companies have submitted formal objections to advisors at the Ministry of Law and Ministry of Finance, expressing their dissatisfaction with the proposed amendments.
The companies argue that the changes could result in a loss of government revenue. However, data from the National Board of Revenue shows that since the enactment of the Smoking and Use of Tobacco Products (Control) Act in 2005, tobacco tax revenues increased by 17.97% in the 2005-2006 fiscal year and by 37.52% in the 2006-2007 fiscal year.
In addition, following an amendment to the law in 2013, tobacco tax revenues increased by 25.51% in fiscal years 2013-2014 and 2014-2015.
ABM Zubair, Executive Director of the anti-tobacco research and advocacy group PROGGA, said: "The Ministry of Health's efforts to strengthen existing tobacco control laws are aimed at protecting non-smokers from secondhand smoke and protecting youth from the harmful effects of tobacco. Therefore, the draft should be passed immediately and not be hindered by the negative tactics of the tobacco industry.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com